Atrial Fibrillation-Reference-Cited by-同舟云学术

Atrial Fibrillation

Published:2011-07-05 Issue:1 Volume:124 Page:95-99
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Ezekowitz Michael D.¹,Aikens Timothy H.¹,Nagarakanti Rangadham¹,Shapiro Timothy¹

Affiliation:

1. From the Lankenau Institute for Medical Research, Wynnewood, PA (M.D.E., T.H.A., T.S.) and Louisiana State University School of Medicine, New Orleans, LA (R.N.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.110.967455

Reference31 articles.

1. Lenient versus Strict Rate Control in Patients with Atrial Fibrillation

2. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

3. A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation

4. A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation

5. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation;JAMA;2021-12-21

2. Management of patients with arterial hypertension and atrial fibrillation;Systemic Hypertension;2021-10-28

3. Features of structural heart remodeling in chronic atrial fibrillation against the background of coronary artery disease with hypertension;Terapevticheskii arkhiv;2018

4. Dabigatran Potentiates Gemcitabine-Induced Growth Inhibition of Pancreatic Cancer in Mice;Molecular Medicine;2017-01

5. Do the benefits of anti-arrhythmic drugs outweigh the associated risks? A tale of treatment goals in atrial fibrillation;Expert Review of Clinical Pharmacology;2012-03